The field of neurodegeneration research has long been focused on finding therapeutic strategies to effectively decrease or halt neuronal loss while minimizing side effects.A recent study titled“Inhibiting acute,axona...The field of neurodegeneration research has long been focused on finding therapeutic strategies to effectively decrease or halt neuronal loss while minimizing side effects.A recent study titled“Inhibiting acute,axonal DLK palmitoylation is neuroprotective and avoids deleterious effects of cell-wide DLK inhibition”(Zhang et al.,2025),describes an innovative approach to achieve this goal.The authors target a specific post-translational modification of dual leucine-zipper kinase(DLK),palmitoylation,to selectively inhibit DLK-dependent pro-degenerative signaling and protect neurons,thereby revealing a new way to intervene and block neurodegeneration.This Perspective aims to explore the significance of these findings and propose directions for future research.展开更多
基金supported by NIH(R01 NS094402 and R21 EY029386)Shriners Children’s(#85190 PHI and#87400 PHI)by BrightFocus Foundation(G2019267)(to GMT).
文摘The field of neurodegeneration research has long been focused on finding therapeutic strategies to effectively decrease or halt neuronal loss while minimizing side effects.A recent study titled“Inhibiting acute,axonal DLK palmitoylation is neuroprotective and avoids deleterious effects of cell-wide DLK inhibition”(Zhang et al.,2025),describes an innovative approach to achieve this goal.The authors target a specific post-translational modification of dual leucine-zipper kinase(DLK),palmitoylation,to selectively inhibit DLK-dependent pro-degenerative signaling and protect neurons,thereby revealing a new way to intervene and block neurodegeneration.This Perspective aims to explore the significance of these findings and propose directions for future research.
